Healius Management
Management criteria checks 1/4
Healius' CEO is Paul Anderson, appointed in Jan 2024, has a tenure of less than a year. total yearly compensation is A$944.62K, comprised of 97.7% salary and 2.3% bonuses, including company stock and options. directly owns 0.005% of the company’s shares, worth A$51.64K. The average tenure of the management team and the board of directors is 1.7 years and 1.8 years respectively.
Key information
Paul Anderson
Chief executive officer
AU$944.6k
Total compensation
| CEO salary percentage | 97.7% |
| CEO tenure | less than a year |
| CEO ownership | 0.005% |
| Management average tenure | 1.7yrs |
| Board average tenure | 1.8yrs |
Recent management updates
Recent updates
Is Healius Limited (ASX:HLS) Trading At A 50% Discount?
Mar 15
At AU$3.07, Is It Time To Put Healius Limited (ASX:HLS) On Your Watch List?
Feb 06Here's Why Healius (ASX:HLS) Can Manage Its Debt Responsibly
Dec 02Is Now An Opportune Moment To Examine Healius Limited (ASX:HLS)?
Oct 13Are Investors Undervaluing Healius Limited (ASX:HLS) By 48%?
Aug 02Why Healius Limited (ASX:HLS) Could Be Worth Watching
May 23Healius Limited's (ASX:HLS) Prospects Need A Boost To Lift Shares
Apr 02Healius (ASX:HLS) Is Paying Out A Larger Dividend Than Last Year
Feb 25CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Jun 30 2024 | AU$945k | AU$923k | -AU$636m |
| Dec 31 2023 | n/a | n/a | -AU$984m |
| Sep 30 2023 | n/a | n/a | -AU$682m |
| Jun 30 2023 | AU$235k | AU$194k | -AU$380m |
Compensation vs Market: Paul's total compensation ($USD590.80K) is below average for companies of similar size in the Australian market ($USD1.04M).
Compensation vs Earnings: Paul's compensation has increased whilst the company is unprofitable.
CEO
Paul Anderson
less than a year
Tenure
AU$944,623
Compensation
Mr. Paul D. Anderson, B COMM, CA serves as Managing Director, Chief Executive Officer since 2024 at Healius Limited and had been Group Chief Financial Officer of Healius Limited since March 1, 2023 and als...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| MD, CEO & Director | less than a year | AU$944.62k | 0.0052% A$ 51.6k | |
| CFO& Company Secretary | 1.8yrs | AU$718.57k | 0.0024% A$ 23.5k | |
| Head & Group Executive of Healius Pathology | 1.5yrs | AU$1.43m | no data | |
| Group Executive of People & Culture | less than a year | no data | no data | |
| Advisor | 5.3yrs | AU$275.71k | 0% A$ 0 | |
| Chief Executive of Lumus Imaging | 1.9yrs | no data | no data | |
| Chief Operating Officer of Healius Pathology | no data | no data | no data | |
| Head of Group FP&A | no data | no data | no data | |
| Group Executive of Operations Transformation | 1.6yrs | no data | no data | |
| Group Executive of Commercial & Customer | 1.7yrs | no data | no data | |
| Head of Digital Strategy & Delivery Office | no data | no data | no data | |
| Company Secretary | 1.8yrs | no data | no data |
1.7yrs
Average Tenure
Experienced Management: HLS's management team is not considered experienced ( 1.7 years average tenure), which suggests a new team.
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| MD, CEO & Director | less than a year | AU$944.62k | 0.0052% A$ 51.6k | |
| Interim Non-Executive Independent Chair | 3.8yrs | AU$269.98k | 0.019% A$ 191.3k | |
| Independent Non-Executive Director | 1.3yrs | AU$138.74k | 0.010% A$ 98.9k | |
| Independent Non-Executive Director | 6.3yrs | AU$185.00k | 0.017% A$ 173.2k | |
| Independent Non-Executive Director | no data | no data | no data | |
| Non Executive & Independent Director | 2.8yrs | AU$170.00k | 0.0075% A$ 74.1k | |
| Independent Non-Executive Director | 1.8yrs | AU$174.82k | 0.018% A$ 181.4k |
1.8yrs
Average Tenure
65yo
Average Age
Experienced Board: HLS's board of directors are not considered experienced ( 1.8 years average tenure), which suggests a new board.
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/23 06:27 |
| End of Day Share Price | 2024/12/23 00:00 |
| Earnings | 2024/06/30 |
| Annual Earnings | 2024/06/30 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Healius Limited is covered by 30 analysts. 9 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Dennis Hulme | APP Securities Pty Ltd. |
| Russell Wright | Barclay Pearce Capital Pty Limited |
| Benjamin Brayshaw | Barrenjoey Markets Pty Limited |